Trial intelligence / Profile preview

Comparison of Two Formulations of GSK's Rotavirus Vaccine in Infants

NCT00137930Phase 2Completed

Sponsor
GSK
Start
Aug 2005
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 2 trial of human rotavirus vaccine, live attenuated in rotavirus gastroenteritis, sponsored by GSK. Started Aug 2005; status: completed.

02

Drugs

human rotavirus vaccine, live attenuated
03

Conditions

rotavirus gastroenteritis

Beyond the preview

Go deeper on NCT00137930.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00137930.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call